Skip to Main Content

Paper Details

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol
0
2023
131-I, Patients, ependymoma, medulloblastoma, omburtamab, patients, primary brain tumors, radiation necrosis, radionecrosis, recurrent
Author NameAffiliation
Matthias A KarajannisMemorial Sloan Kettering Cancer Center
Mark M SouweidaneMemorial Sloan Kettering Cancer Center
Mark M SouweidaneMemorial Sloan Kettering Cancer Center
Neeta Pandit-TaskarMemorial Sloan Kettering Cancer Center
John L HummMemorial Sloan Kettering Cancer Center
John L HummMemorial Sloan Kettering Cancer Center
  • 1 - 6

Datasets

Release 1.2